Developmental neurotoxicity of perfluorinated chemicals modeled in vitro

Environmental Health Perspectives

Volumn 116, Issue 6, 2008, Pages 716-722

  Slotkin, Theodore A ^a   MacKillop, Emiko A ^a   Meinick, Ronald L ^b   Thayer, Kristina A ^b   Seidler, Frederic J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Developmental neurotoxicity; PC12 cells; Perfluorinated chemicals; Perfluoroalkyl acids; Perfluorobutane sulfonate; Perfluorooctane sulfonamide; Perfluorooctane sulfonate; Perfluorooctanoate; Perfluorooctanoic acid

Indexed keywords

ACETYLCHOLINE; DOPAMINE; NEUROTRANSMITTER; ORGANOFLUORINE DERIVATIVE; PERFLUORO COMPOUND; PERFLUOROBUTANESULFONIC ACID; PERFLUOROOCTANE SULFONAMIDE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BRAIN DEVELOPMENT; CELL COUNT; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; IN VITRO STUDY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL;

ALKANESULFONIC ACIDS; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; FLUOROCARBONS; NEURONS; OCTANOIC ACIDS; OXIDATIVE STRESS; PC12 CELLS; RATS; SULFONAMIDES;

EID: 46749150654     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.11253     Document Type: Article

References (65)

1. M. 2007. Information about PFOS and PFOA. Available: http://solutions.3m.com/wps/portal/3M/en_US/PFOS/PFOA [accessed 14 December 2007].
2. Bagchi D, Bagchi M, Hassoun EA, Stohs SJ. 1995. In vitro and in vivo generation of reactive oxygen species, DNA damage and lactate dehydrogenase leakage by selected pesticides. Toxicology 104:129-140.
3. Barone S, Das KP, Lassiter TL, White LD. 2000. Vulnerable processes of nervous system development: a review of markers and methods. Neurotoxicology 21:15-36.
4. Bell JM, Whitmore WL, Slotkin TA. 1986. Effects of α-difluoro-methylornithine, a specific irreversible inhibitor of ornithine decarboxylase, on nucleic acids and proteins in developing rat brain: critical perinatal periods for regional selectivity. Neuroscience 17:399-407.
5. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Tully JS, Needham LL. 2007a. Serum concentrations of 11 polyfluoroalkyl compounds in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES). Environ Sci Technol 41:2237-2242.
6. Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. 2007b. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115:1596-1602.
7. Costa LG. 1998. Neurotoxicity testing: a discussion of in vitro alternatives. Environ Health Perspect 106(suppl 2):505-510.
8. Crofton KM, Foss JA, Hass U, Jensen KF, Levin ED, Parker SP. In press. Undertaking positive control studies as part of developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol Teratol doi:10.1016/j.ntt.2007.06.002 [15 June 2007].
9. Crumpton T, Atkins DS, Zawia NH, Barone S Jr. 2001. Lead exposure in pheochromocytoma (PC12) cells alters neural differentiation and Sp1 DNA-binding. Neurotoxicology 22:49-62.
10. Crumpton TL, Seidler FJ, Slotkin TA. 2000a. Developmental neurotoxicity of chlorpyrifos in vivo and in vitro: effects on nuclear transcription factor involved in cell replication and differentiation. Brain Res 857:87-98.
11. Crumpton TL, Seidler FJ, Slotkin TA. 2000b. Is oxidative stress involved in the developmental neurotoxicity of chlorpyrifos? Dev Brain Res 121:189-195.
12. Dam K, Garcia SJ, Seidler FJ, Slotkín TA, 1999. Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Dev Brain Res 116:9-20.
13. Das KP, Barone S. 1999. Neuronal differentiation in PC12 cells is inhibited by chlorpyrifos and its metabolites: is acetylcholinesterese inhibition the site of action? Toxicol Appl Pharmacol 160:217-230.
14. 2OH: kinetics and mechanism of reaction with OH. Environ Sci Technol 40:1862-1868.
15. D'Eon JC, Mabury SA. 2007. Production of perfluorinated carboxylic acids (PFCAs) from the biotransformation of polyfluoroalkyl phosphate surfactants (PAPS): exploring routes of human contamination. Environ Sci Technol 41:4799-4805.
16. Flaskas J, McLean WG, Hargreaves AJ. 1994. The toxicity of organophosphate compounds towards cultured PC12 cells. Toxicol Lett 70:71-76.
17. Fujita K, Lazarovici P, Guroff G. 1989. Regulation of the differentiation of PC12 pheochromocytoma cells. Environ Health Perspect 80:127-142.
18. Guan ZZ, Yu WF, Nordberg A. 2003. Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochem Int 43:243-249.
19. Harada KH, Ishii TM, Takatsuka K, Koizumi A, Ohmori H. 2006. Effects at perfluorooctane sulfonate on action potentials and currents in cultured rat cerebellar Purkinje cells. Biochem Biophys Res Comm 351:240-245.
20. Jameson RR, Seidler FJ, Diao D, Slotkin TA, 2006a. Adverse neurodevelopmental effects of dexamethasone modeled in PC12 cells: identifying the critical stages and concentration thresholds for the targeting of cell acquisition, differentiation and viability. Neuropsychopharmacology 31:1647-1658.
21. Jameson RR, Seidler FJ, Qiao D, Slotkin TA. 2006b. Chlorpyrifos affects phenotypic outcomes in a model of mammalian neurodevelopment critical stages targeting differentiation in PC12 cells. Environ Health Perspect 114:667-672.
22. Jameson RR, Seidler FJ, Slotkin TA. 2007. Nonenzymatic functions of acetylcholinesterase splice variants in the developmental neurotaxicity of organophosphates: chlorpyrifos, chlorpyritos oxon, and diazinon. Environ Health Perspect 115:65-70.
23. Johansson N, Fredriksson A, Eriksson P. 2008. Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctenoic acid (PFOA) causes neurobehavioural defects in adult mice. Neurotoxirology 29:160-169.
24. Katoh S, Mitsui Y, Kitani K, Suzuki T. 1997. Hyperoxia induces the differentiated neuronal phenotype of PC12 cells by producing reactive oxygen species. Biochem Biophys Res Commun 241:347-351.
25. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hatchens A, Seed J. 2007. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366-394.
26. Lau C, Butenhoff JL, Rogers JM. 2004. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198:231-241.
27. Lau C, Seidler FJ, Cameron AM, Navarro HA, Bell JM, Bartolome J, et al. 1988. Nutritional influences on adrenal chromaffin cell development: comparison with central neurons. Pediatr Res 24:583-587.
28. Lau C, Thibodeaux JR, Hanson RG. Narotsky MG, Rogers JM, Lindstrom AS, et al. 2006. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 90:510-518.
29. Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, et al. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicoll Sci 74:382-392.
30. Li YX, King MA, Grimes J, Smith N, de Fiebre CM, Meyer EM. 1999. α7 Nicotinic receptor mediated protection against ethanol-induced cytotoxicity in PC12 cells. Brain Res 816:225-228.
31. Luebker DJ, Cass MT, York RG, Moore JA, Hansen KJ, Butenhoff JL. 2005a. Two-generation reproduction and cross-foster studies of perfluorooctonesulfonate (PFOS) in rats. Toxicology 215:126-148.
32. Luebker DJ, York, RG, Hansen KJ, Moore JA, Butenhoff JL. 2005b. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology 215:149-169.
33. Olsen GW, Burris JM, Burlew MM, Mandel JH. 2003a. Epidemiologic assessment of worker serum perfluoro-octanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 45:260-270.
34. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. 2007. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298-1305.
35. Olsen GW, Burris JM, Mandel JH, Zobel LR. 1999. Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. J Occup Environ Med 41:799-806.
36. Olsen GW, Gilliland FD, Burlew MM, Burris JM, Mandel JS, Mandel JH. 1998. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J Occup Environ Med 40:614-622.
37. Olson GW, Logan PW, Hansen KJ, Simpson CA, Burris JM, Burlew MM, et al. 2003b. An occupational exposure assessment of a perfluorooctanesulfonyl fluoride production site: biomonitoring. AIHA J (Fairfax, VA) 64:651-659.
38. Pope CN. 1999. Organophosphorus pesticides: do they all have the same mechanism of toxicity? J Toxicol Environ Health 2:161-181.
39. Qiao D, Seidler FJ, Slotkin TA. 2001. Developmental neurotoxicity of chlorpyrifos modeled in vitro: comparative effects of metabolites and other cholinesterase inhibitors on DNA synthesis in PC12 and C6 cells. Environ Health Perspect 109:909-913.
40. Qiao D, Seidler FJ, Slotkin TA. 2005. Oxidative mechanisms contributing to the developmental neurotoxicity of nicotine and chlorpyrifos. Toxicol Appl Pharmacol 206:17-26.
41. Qiao D, Seidler FJ, Violin JD, Slotkin TA. 2003. Nicotine is a developmental neurotoxicant and neuroprotectant stage-selective inhibition of DNA synthesis coincident with shielding from effects of chlorpyrifos. Dev Brain Res 147:183-190.
42. Ramesh GT, Manna SK, Aggarwal BB, Jadhav AL. 1999. Lead activates nuclear transcription factor-κB, activator protein-1 and amino-terminal c-Jun kinase in pheochromocytoma cells. Toxicol Appl Pharmacol 155:280-286.
43. Rice D, Barone S. 2000. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108(suppl 3):511-533.
44. Schroder HF. 2003. Determination of fluorinated surfactants and their metabolites in sewage sludge samples by liquid chromatography with mass spectrometry and tandem mass spectrometry after pressurised liquid extraction and separation on fluorine-modified reversed-phase sorbents. J Chromatogr A 1020:131-151.
45. Schultz MM, Higgins CP, Huset CA, Luthy RG, Barofsky DF, Field JA. 2006. Fluorochemical mass flows in a municipal wastewater treatment facility. Environ Sci Technol 40:7350-7357.
46. Slotkin TA. 1999. Developmental cholinotoxicants: nicotine and chlorpyrifos. Environ Health Perspect 107(suppl 1):71-80.
47. Slotkin TA. 20004a. Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol Appl Pharmacol 198:132-151.
48. Slotkin TA. 2004b. Guidelines for developmental neurotoxicity and their impact on organophosphate pesticides: a personal view from an academic perspective. Neurotoxicology 25:631-640.
49. Slotkin TA. 2005. Developmental neurotoxicity of organophosphates: a case study of chlorpyrifos. In: Toxicity of Organophosphate and Carbamate Pesticides (Gupta RC, ed). San Diego:Elsevier Academic Press, 293-314.
50. Slotkin TA, MacKillop EA, Ryde IT, Tate CA, Seidler FJ. 2007. Screening for developmental neurotoxicity using PC12 cells: comparisons of organophosphates with a carbamate, an organochlorine and divalent nickel. Environ Health Perspect 115:93-101.
51. Slotkin TA, Persons D, Slepetis RJ, Taylor D, Bartolome J. 1984. Control of nucleic acid and protein synthesis in developing brain, kidney, and heart of the neonatal rat: effects of α-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase. Teratology 30:211-224.
52. Slotkin TA, Seidler FJ. 2007. Comparative developmental neurotoxicity of organophosphates in vivo: transcriptional responses of pathways for brain cell development cell signaling, cytotoxicity and neurotransmitter systems. Brain Res Bull 72:232-274.
53. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
54. Song X, Violin JD, Seidler FJ, Slotkin TA. 1998. Modeling the developmental neurotoxicity of chlorpyrifos in vitro: macromolecule synthesis in PC12 calls. Toxicol Appl Pharmacol 151:182-191.
55. Starkov AA, Wallace KB. 2002. Structural determinants of fluorochemical-induced mitochondrial dysfunction. Toxicol Sci 66:244-252
56. Teng KK, Greene LA. 1994. Cultured PC12 calls: a model for neuronal function and differentiation. In: Cell Biology: A Laboratory Handbook (Celis JE. ed). San Diego:Academic Press,218-224.
57. Thai L, Galluzzo JM, McCook EC, Seidler FJ, Slotkin TA. 1996. Atypical regulation of hepatic adenylyl cyclase and adrenergic receptors during a critical developmental period: agonists evoke supersensitivity accompanied by failure of receptor downregulation. Pediatr Res 39:697-707.
58. Trauth JA, Seidler FJ, Slotkin TA. 2000. An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions. Brain Res 867:29-39.
59. Tuler SM, Hazen AA, Bowen JM. 1989. Release and metabolism of dopamine in a clonal line of pheochromocytoma (PC12) cells exposed to fenthion. Fundam Appl Toxicol 13:484-492.
60. U.S. Environmental Protection Agency. 2006. 2010/15 PFOA Stewardship Program. Available: http://www.epa.gov/opptintr/pfoa/pubs/ pfoastewardship.htm [accessed 14 December 2007].
61. Vidair CA. 2004. Age dependence of organophosphate and carbamate neurotoxicity in the postnatal rat: extrapolation to the human. Toxicol Appl Pharmacol 196:287-302.
62. 14C-L-tyrosine. Anal Biochem 43-588-600.
63. Winick M, Noble A. 1965. Quantitative changes in DNA, RNA and protein during prenatal and postnatal growth in the rat. Dev Bioll 12:451-466.
64. Xu L, Krenitsky DM, Seacat AM, Butenhoff JL. Anders MW. 2004. Biotransformation of N-ethyl-N(2-hydroxyethyl)perfluorooctanasulfonamide by rat liver microsomes, cytosol, and slices and by expressed rat and human cytochromes P450. Chem Res Toxicol 17:767-775.
65. Xu L, Krenitsky DM, Seacat AM, Butenhoff JL, Tephly TR, Anders MW. 2006. N-Glucuronidation of perfluorooctanesulfonamide by human, rat dog, and monkey liver microsomes and by expressed rat and human UDP-glucuronosyl-transferases. Drug Metab Dispos 34:1406-1410.